Better data.
Better research.

Acclinate integrates culture and technology to achieve more inclusive clinical research.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Health equity through inclusive research

We help pharmaceutical companies, CROs, and healthcare organizations access and engage communities of color so their research efforts are more inclusive and reflect the populations they serve.

#NOWINCLUDED

#NOWINCLUDED is a digital platform that educates and engages diverse individuals on important health decisions.

Learn More

e-DICT

e-DICT is our HIPAA-compliant platform that sources diverse clinical trial participants.

Learn More

Awareness to Participation

Early awareness and engagement is necessary when working with communities of color who may be skeptical of participating in clinical research.
Acclinate uses a proven, three-tiered, three-phased approach to move from community awareness to participation.

Phase 1
Awareness

Acclinate increases awareness of research-related health topics in communities of color through #NOWINCLUDED, our digital health platform.

Phase 2
Engagement

With our team of specialists, Acclinate engages most likely participants of specific research-related health issues (e.g., health disparities, common misdiagnosis, sources of information, options for care).

Phase 3
Participation

Acclinate's predictive analytics software, e-DICT, helps pharmaceutical companies and health organizations identify and hyper-target likely participants for their clinical research, driving down recruitment costs and increasing diverse enrollment.

Learn how e-DICT can help increase the diversity of your clinical trial

Request A Demo

Rett Syndrome and Rallying Around Tiana:
Why The Vega Family Participates In Clinical Trials

Read how #NOWINCLUDED is helping healthcare organizations that are using Acclinate to reach and engage diverse individuals, families, and communities.

Download

Results

35%

Month-over-month community growth

7,500

Total participants sought for current client studies

14%

Average diversity target for current client studies

Trusted by

What People Are Saying

"Trust is driven by relationships. The key to diversity is inclusion, we strive to include minorities in conversations, not as a statistic, as a human being."

Tiffany Whitlow
Co-Founder, CDO
Acclinate

“We partnered with Acclinate because their platform and services will lead to successful recruitment and engagement of study participants for our first of its kind, ARGONAUT study.”

Stephanie Culler, Ph.D.
Co-Founder, CEO
Persephone Biosciences, Inc.

“Acclinate is at the forefront of implementing a portal to make certain minorities are included in clinical trials.”

Randall Moreadith, MD, PhD
President
Serina Therapeutics

Learn how you can improve the diversity of your clinical trials today.

Contact Us